Global Dengue Vaccine Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Dengue is a mosquito-borne infectious disease affecting humans and animals caused by the dengue virus belonging to the flaviviridae family and genus Flavivirus. Dengue is typically transmitted from human to human through the bite of an infected Aedes aegypti mosquito. Symptoms of dengue include high fever, headache, fatigue, muscle pain, diarrhea, anemia, skin rashes, and vomiting. Severe dengue can cause yellow skin, seizures, comas, or death. Dengue has a high mortality rate and can cause various complications in neurology. The global dengue vaccine market is anticipated to record a CAGR of around 23% over the forecast period.
The rising number of dengue cases observed around the world is the primary driver.
Growing clinical advancements observed in the development of vaccines for dengue fever along with the concern for dengue disease occurring worldwide are anticipated to contribute towards the growth of the global dengue vaccine market. According to the statistics by the World Health Organization (WHO), the total number of dengue cases around the world has observed an over fifteen-fold increase, raising the number to reach a total of up to 3,312,040 in the year 2015.
Also, the market is primarily driven by the rising number of dengue cases observed around the world, which is affecting millions of people, thereby raising the need to get vaccinated by the dengue vaccine. According to the World Health Organization, around 100400 million dengue infections are estimated to occur around the globe each year. The statistics also stated that more than half of the worlds population is at risk of being affected by dengue fever.
Hospitals, pharmacies, measurement-type to make a Crucial Contribution to the Growth of the Tunable Diode Laser Analyzer Market.
Based on distribution channels, the market has been classified into hospital pharmacies, retail pharmacies, drug stores, online pharmacies, and others. The hospitals pharmacy segment held the largest share of the market due to easy access for outpatient department (OPD) patients to buy medicines. Online pharmacies are likely to witness lucrative growth during the forecast period due to increasing online purchases by patients and various discounts offered by online stores.
The global dengue vaccine market is segmented into end-user types such as government institutions and private institutions. Among these segments, the government institutions segment is expected to occupy the top position in the market during the forecast period. The rise of the government institution segment is backed by favourable government initiatives and programmes to provide dengue vaccines to the population at affordable prices. Further, the increasing number of patients suffering from dengue infection and improving healthcare infrastructure are major factors that are escalating the growth of the dengue vaccine market across the globe.
North America is expected to witness the fastest growth in the dengue vaccine market.
North America (the United States and Canada), Europe (Germany, France, the United Kingdom, and so on), Asia-Pacific (Australia, China, Japan, India, and so on), Latin America (Brazil, Mexico, and so on), and the Middle East and Africa (GCC Countries, South Africa, and so on). America is the leading market for dengue vaccines, followed by Europe. The U.S. holds the largest share of the market in the region. Asia-Pacific and Latin America are emerging markets that are expected to witness strong growth during the forecast period from 2017 to 2025. Strong growth in these regions is attributed to the increasing incidence of dengue, rising health care industries, and an increase in government investment to develop health care infrastructure. The dengue vaccine market in countries such as China, India, and Brazil is projected to expand at a high growth rate during the forecast period due to an increase in awareness among the population about dengue disease and its treatment.
Players to Focus on Dengue Vaccine Market
Major Players operating in the dengue vaccine market include
Sanofi Pasteur,
Panacea Biotec,
Biological E. Limited,
GlaxoSmithKline plc,
Merck & Co., Inc.
Takeda Pharmaceutical Company Ltd.
Scope of the Report
By End-user
hospitals pharmacies
Government Institutions
Private Institutions
By Region
North America
Europe
Asia Pacific
Rest Of World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
The rising number of dengue cases observed around the world is the primary driver.
Growing clinical advancements observed in the development of vaccines for dengue fever along with the concern for dengue disease occurring worldwide are anticipated to contribute towards the growth of the global dengue vaccine market. According to the statistics by the World Health Organization (WHO), the total number of dengue cases around the world has observed an over fifteen-fold increase, raising the number to reach a total of up to 3,312,040 in the year 2015.
Also, the market is primarily driven by the rising number of dengue cases observed around the world, which is affecting millions of people, thereby raising the need to get vaccinated by the dengue vaccine. According to the World Health Organization, around 100400 million dengue infections are estimated to occur around the globe each year. The statistics also stated that more than half of the worlds population is at risk of being affected by dengue fever.
Hospitals, pharmacies, measurement-type to make a Crucial Contribution to the Growth of the Tunable Diode Laser Analyzer Market.
Based on distribution channels, the market has been classified into hospital pharmacies, retail pharmacies, drug stores, online pharmacies, and others. The hospitals pharmacy segment held the largest share of the market due to easy access for outpatient department (OPD) patients to buy medicines. Online pharmacies are likely to witness lucrative growth during the forecast period due to increasing online purchases by patients and various discounts offered by online stores.
The global dengue vaccine market is segmented into end-user types such as government institutions and private institutions. Among these segments, the government institutions segment is expected to occupy the top position in the market during the forecast period. The rise of the government institution segment is backed by favourable government initiatives and programmes to provide dengue vaccines to the population at affordable prices. Further, the increasing number of patients suffering from dengue infection and improving healthcare infrastructure are major factors that are escalating the growth of the dengue vaccine market across the globe.
North America is expected to witness the fastest growth in the dengue vaccine market.
North America (the United States and Canada), Europe (Germany, France, the United Kingdom, and so on), Asia-Pacific (Australia, China, Japan, India, and so on), Latin America (Brazil, Mexico, and so on), and the Middle East and Africa (GCC Countries, South Africa, and so on). America is the leading market for dengue vaccines, followed by Europe. The U.S. holds the largest share of the market in the region. Asia-Pacific and Latin America are emerging markets that are expected to witness strong growth during the forecast period from 2017 to 2025. Strong growth in these regions is attributed to the increasing incidence of dengue, rising health care industries, and an increase in government investment to develop health care infrastructure. The dengue vaccine market in countries such as China, India, and Brazil is projected to expand at a high growth rate during the forecast period due to an increase in awareness among the population about dengue disease and its treatment.
Players to Focus on Dengue Vaccine Market
Major Players operating in the dengue vaccine market include
Sanofi Pasteur,
Panacea Biotec,
Biological E. Limited,
GlaxoSmithKline plc,
Merck & Co., Inc.
Takeda Pharmaceutical Company Ltd.
Scope of the Report
By End-user
hospitals pharmacies
Government Institutions
Private Institutions
By Region
North America
Europe
Asia Pacific
Rest Of World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
TABLE OF CONTENTS
Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Dengue Vaccine Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Dengue Vaccine Market -Industry Snapshots
6.1 Overview
6.1.1 Global Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Dengue Vaccine Market Analysis, by End user Overview
7.1 Key Findings for Dengue Vaccine Market- By End userDengue Vaccine Market- hospitals pharmacies
7.1.1 Dengue Vaccine Market- Government Institutions
Chapter 8 Global Dengue Vaccine Market Analysis, by Application
8.1 Overview
8.2 Key Findings for Dengue Vaccine Market- By Application
8.2.1 Dengue Vaccine Market- Column Assisted Dengue Vaccine (C-EPS)
8.2.2 Dengue Vaccine Market- Pinion Assisted Dengue Vaccine (P-EPS)
8.2.3 Dengue Vaccine Market- Rack Assisted Power Steering System (R-EPS)
8.2.4 Dengue Vaccine Market- Electronic Hydraulic Power Steering (EHPS)
8.2.5 Dengue Vaccine Market- Electronic Hydraulic Power Steering (EHPS)
Chapter 9 Dengue Vaccine Market Analysis by Region
9.1 Key Findings for Dengue Vaccine Market- By region
9.2 Overview
9.2.1 Global Dengue Vaccine Market Analysis, By Type, 2019 - 2030
9.2.2 Global Dengue Vaccine Market Analysis, By Application, 2019 - 2030
9.3 Dengue Vaccine Market North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Application
9.4 Dengue Vaccine Market Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Application
9.5 Dengue Vaccine Market Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Application
9.6 Dengue Vaccine Market Rest Of World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 South America
9.6.4 Rest Of World
9.6.5 South America, Middle East and Africa Market, By Type
9.6.6 South America, Middle East and Africa Market, By Application
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments
Chapter 11 Company Profiles- Snapshot
11.1.1 Takeda Pharmaceutical Company Ltd
11.1.2 Business Fundamentals
11.1.3 Financial Snapshots
11.1.4 Product Portfolio
11.1.5 Recent Developments
11.2 Sanofi Pasteur,
11.3 Panacea Biotec,
11.4 Biological E. Limited,
11.5 GlaxoSmithKline plc,
11.6 Merck & Co., Inc.
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 12 Appendix
TABLE 2 Dengue Vaccine market by End user 2, 2018 - 2026 (USD Million)
TABLE 3 Dengue Vaccine market by Application 1, 2018 - 2026 (USD Million)
TABLE 4 Dengue Vaccine market by Application 2, 2018 - 2026 (USD Million)
TABLE 5 Dengue Vaccine market by Application 3, 2018 - 2026 (USD Million)
TABLE 6 Dengue Vaccine market by Application 4, 2018 - 2026 (USD Million)
TABLE 7 Dengue Vaccine market by Application 5, 2018 - 2026 (USD Million)
TABLE 8 Global Dengue Vaccine Market Value, By Type, 2019 - 2030 (US$ Bn)
TABLE 9 Global Dengue Vaccine Market Value, By Application, 2019 - 2030 (US$ Bn)
TABLE 10 Dengue Vaccine Market Analysis by North America (USD Million), 2018-2026
TABLE 11 U.S. Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 12 U.S. Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 13 U.S. Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 14 Canada Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 15 Canada Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 16 Canada Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 17 Mexico Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 18 Mexico Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 19 Mexico Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 20 Dengue Vaccine Market Analysis by Europe (USD Million), 2018-2026
TABLE 21 Germany Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 22 Germany Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 23 Germany Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 24 United Kingdom Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 25 United Kingdom Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 26 United Kingdom Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 27 France Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 28 France Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 29 France Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 30 Italy Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 31 Italy Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 32 Italy Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 33 Rest Of Europe Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 34 Rest Of Europe Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 35 Rest Of Europe Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 36 Dengue Vaccine Market Analysis by Asia Pacific (USD Million), 2018-2026
TABLE 37 China Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 38 China Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 39 China Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 40 Japan Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 41 Japan Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 42 Japan Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 43 India Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 44 India Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 45 India Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 46 Rest of APAC Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 47 Rest of APAC Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 48 Rest of APAC Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 49 Dengue Vaccine Market Analysis by Rest Of World (USD Million), 2018-2026
TABLE 50 Middle East & Africa (MEA) Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 51 Middle East & Africa (MEA) Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 52 Middle East & Africa (MEA) Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 53 South America Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 54 South America Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 55 South America Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 56 Rest Of World Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 57 Rest Of World Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 58 Rest Of World Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
FIG. 2 Global Dengue Vaccine Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Dengue Vaccine Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Dengue Vaccine Market Value Contribution, By Application, 2019 & 2026 (%)
FIG. 10 Global Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 11 North America Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 12 Dengue Vaccine Market Segment 1 North America
FIG. 13 Dengue Vaccine Market Segment 2 North America
FIG. 14 Dengue Vaccine U.S. outlook, 2019 & 2026
FIG. 15 Dengue Vaccine Canada outlook, 2019 & 2026
FIG. 16 Dengue Vaccine Mexico outlook, 2019 & 2026
FIG. 17 Europe Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 18 Dengue Vaccine Market Segment 1 Europe
FIG. 19 Dengue Vaccine Market Segment 2 Europe
FIG. 20 Dengue Vaccine Germany outlook, 2019 & 2026
FIG. 21 Dengue Vaccine United Kingdom outlook, 2019 & 2026
FIG. 22 Dengue Vaccine France outlook, 2019 & 2026
FIG. 23 Dengue Vaccine Italy outlook, 2019 & 2026
FIG. 24 Dengue Vaccine Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 26 Dengue Vaccine Market Segment 1 Asia Pacific
FIG. 27 Dengue Vaccine Market Segment 2 Asia Pacific
FIG. 28 Dengue Vaccine China outlook, 2019 & 2026
FIG. 29 Dengue Vaccine Japan outlook, 2019 & 2026
FIG. 30 Dengue Vaccine India outlook, 2019 & 2026
FIG. 31 Dengue Vaccine Rest of APAC outlook, 2019 & 2026
FIG. 32 Rest Of World Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 33 Dengue Vaccine Market Segment 1 Rest Of World
FIG. 34 Dengue Vaccine Market Segment 2 Rest Of World
FIG. 35 Dengue Vaccine Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Dengue Vaccine South America outlook, 2019 & 2026
FIG. 37 Dengue Vaccine Rest Of World outlook, 2019 & 2026
Companies Mentioned
Merck & Co. Inc.
Sanofi
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Institut Pasteur.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Dengue Vaccine Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Dengue Vaccine Market -Industry Snapshots
6.1 Overview
6.1.1 Global Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Dengue Vaccine Market Analysis, by End user Overview
7.1 Key Findings for Dengue Vaccine Market- By End userDengue Vaccine Market- hospitals pharmacies
7.1.1 Dengue Vaccine Market- Government Institutions
Chapter 8 Global Dengue Vaccine Market Analysis, by Application
8.1 Overview
8.2 Key Findings for Dengue Vaccine Market- By Application
8.2.1 Dengue Vaccine Market- Column Assisted Dengue Vaccine (C-EPS)
8.2.2 Dengue Vaccine Market- Pinion Assisted Dengue Vaccine (P-EPS)
8.2.3 Dengue Vaccine Market- Rack Assisted Power Steering System (R-EPS)
8.2.4 Dengue Vaccine Market- Electronic Hydraulic Power Steering (EHPS)
8.2.5 Dengue Vaccine Market- Electronic Hydraulic Power Steering (EHPS)
Chapter 9 Dengue Vaccine Market Analysis by Region
9.1 Key Findings for Dengue Vaccine Market- By region
9.2 Overview
9.2.1 Global Dengue Vaccine Market Analysis, By Type, 2019 - 2030
9.2.2 Global Dengue Vaccine Market Analysis, By Application, 2019 - 2030
9.3 Dengue Vaccine Market North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Application
9.4 Dengue Vaccine Market Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Application
9.5 Dengue Vaccine Market Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Application
9.6 Dengue Vaccine Market Rest Of World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 South America
9.6.4 Rest Of World
9.6.5 South America, Middle East and Africa Market, By Type
9.6.6 South America, Middle East and Africa Market, By Application
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments
Chapter 11 Company Profiles- Snapshot
11.1.1 Takeda Pharmaceutical Company Ltd
11.1.2 Business Fundamentals
11.1.3 Financial Snapshots
11.1.4 Product Portfolio
11.1.5 Recent Developments
11.2 Sanofi Pasteur,
11.3 Panacea Biotec,
11.4 Biological E. Limited,
11.5 GlaxoSmithKline plc,
11.6 Merck & Co., Inc.
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 12 Appendix
List Of Tables
TABLE 1 Dengue Vaccine market by End user 1, 2018 - 2026 (USD Million)TABLE 2 Dengue Vaccine market by End user 2, 2018 - 2026 (USD Million)
TABLE 3 Dengue Vaccine market by Application 1, 2018 - 2026 (USD Million)
TABLE 4 Dengue Vaccine market by Application 2, 2018 - 2026 (USD Million)
TABLE 5 Dengue Vaccine market by Application 3, 2018 - 2026 (USD Million)
TABLE 6 Dengue Vaccine market by Application 4, 2018 - 2026 (USD Million)
TABLE 7 Dengue Vaccine market by Application 5, 2018 - 2026 (USD Million)
TABLE 8 Global Dengue Vaccine Market Value, By Type, 2019 - 2030 (US$ Bn)
TABLE 9 Global Dengue Vaccine Market Value, By Application, 2019 - 2030 (US$ Bn)
TABLE 10 Dengue Vaccine Market Analysis by North America (USD Million), 2018-2026
TABLE 11 U.S. Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 12 U.S. Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 13 U.S. Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 14 Canada Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 15 Canada Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 16 Canada Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 17 Mexico Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 18 Mexico Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 19 Mexico Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 20 Dengue Vaccine Market Analysis by Europe (USD Million), 2018-2026
TABLE 21 Germany Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 22 Germany Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 23 Germany Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 24 United Kingdom Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 25 United Kingdom Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 26 United Kingdom Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 27 France Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 28 France Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 29 France Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 30 Italy Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 31 Italy Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 32 Italy Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 33 Rest Of Europe Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 34 Rest Of Europe Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 35 Rest Of Europe Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 36 Dengue Vaccine Market Analysis by Asia Pacific (USD Million), 2018-2026
TABLE 37 China Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 38 China Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 39 China Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 40 Japan Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 41 Japan Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 42 Japan Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 43 India Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 44 India Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 45 India Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 46 Rest of APAC Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 47 Rest of APAC Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 48 Rest of APAC Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 49 Dengue Vaccine Market Analysis by Rest Of World (USD Million), 2018-2026
TABLE 50 Middle East & Africa (MEA) Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 51 Middle East & Africa (MEA) Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 52 Middle East & Africa (MEA) Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 53 South America Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 54 South America Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 55 South America Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
TABLE 56 Rest Of World Dengue Vaccine Market, 2018 - 2026 (USD Million)
TABLE 57 Rest Of World Dengue Vaccine Market, By Type, 2018 - 2026 (USD Million)
TABLE 58 Rest Of World Dengue Vaccine Market, By Application, 2018 - 2026 (USD Million)
List Of Figures
FIG. 1 Global Ammonium sulphate: Market SegmentationFIG. 2 Global Dengue Vaccine Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Dengue Vaccine Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Dengue Vaccine Market Value Contribution, By Application, 2019 & 2026 (%)
FIG. 10 Global Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 11 North America Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 12 Dengue Vaccine Market Segment 1 North America
FIG. 13 Dengue Vaccine Market Segment 2 North America
FIG. 14 Dengue Vaccine U.S. outlook, 2019 & 2026
FIG. 15 Dengue Vaccine Canada outlook, 2019 & 2026
FIG. 16 Dengue Vaccine Mexico outlook, 2019 & 2026
FIG. 17 Europe Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 18 Dengue Vaccine Market Segment 1 Europe
FIG. 19 Dengue Vaccine Market Segment 2 Europe
FIG. 20 Dengue Vaccine Germany outlook, 2019 & 2026
FIG. 21 Dengue Vaccine United Kingdom outlook, 2019 & 2026
FIG. 22 Dengue Vaccine France outlook, 2019 & 2026
FIG. 23 Dengue Vaccine Italy outlook, 2019 & 2026
FIG. 24 Dengue Vaccine Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 26 Dengue Vaccine Market Segment 1 Asia Pacific
FIG. 27 Dengue Vaccine Market Segment 2 Asia Pacific
FIG. 28 Dengue Vaccine China outlook, 2019 & 2026
FIG. 29 Dengue Vaccine Japan outlook, 2019 & 2026
FIG. 30 Dengue Vaccine India outlook, 2019 & 2026
FIG. 31 Dengue Vaccine Rest of APAC outlook, 2019 & 2026
FIG. 32 Rest Of World Dengue Vaccine Market Value, 2019 - 2030, (US$ Bn)
FIG. 33 Dengue Vaccine Market Segment 1 Rest Of World
FIG. 34 Dengue Vaccine Market Segment 2 Rest Of World
FIG. 35 Dengue Vaccine Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Dengue Vaccine South America outlook, 2019 & 2026
FIG. 37 Dengue Vaccine Rest Of World outlook, 2019 & 2026
Companies Mentioned
Merck & Co. Inc.
Sanofi
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Institut Pasteur.
RELATED REPORTS
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
View ReportGlobal Dengue Drug Market Research Report 2017
Dengue Drug Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth research report on the worlds major regional market conditions, focusing on the
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
